Condition: Aspirin · Gastric Cancer · Sponsor: National Cancer Center, Korea
This study aimed to investigate the effect of low-dose (100 mg) asprin on the prevention of gastric cancer in the early gastric cancer patients with negative H. pylori status who underwent endoscopic submucosal dissection.
This description comes directly from the study's public registry record.
Il Ju Choi, M.D., Ph.D. · +82-31-920-2282 · cij1224@ncc.re.kr
Young-Il Kim, MD · +82-31-920-1712 · 11996@ncc.re.kr
Always discuss trial participation with your own doctor first.
| Pusan National University Hospital | Busan, South Korea | Recruiting |
| Kosin University Gospel Hospital | Busan, South Korea | Recruiting |
| Hallym University Chuncheon Sacred Heart Hospital | Chuncheon, South Korea | Recruiting |
| Kyungpook National University Chilgok Hospital | Daegu, South Korea | Recruiting |
| National Cancer Center | Goyang, South Korea | Recruiting |
| Chonnam National University Hospital | Gwangju, South Korea | Recruiting |
| Incheon St.Mary's Hospital/The Catholic University | Incheon, South Korea | Recruiting |
| Chung-Ang University Hospital | Seoul, South Korea | Recruiting |
| SMG-SNU Boramae Medical Center | Seoul, South Korea | Recruiting |
| Asan Medical Center | Seoul, South Korea | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04214990